Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on CareDx (CDNA – Research Report) and InflaRx (IFRX – Research Report).
CareDx (CDNA)
H.C. Wainwright analyst Yi Chen reiterated a Hold rating on CareDx today. The company’s shares closed last Wednesday at $11.44, close to its 52-week low of $11.26.
According to TipRanks.com, Chen has currently 0 stars on a ranking scale of 0-5 stars, with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for CareDx with a $31.50 average price target.
See the top stocks recommended by analysts >>
InflaRx (IFRX)
In a report released today, Edward White from H.C. Wainwright maintained a Buy rating on InflaRx, with a price target of $8.00. The company’s shares closed last Wednesday at $2.70.
According to TipRanks.com, White has 0 stars on 0-5 stars ranking scale with an average return of
InflaRx has an analyst consensus of Strong Buy, with a price target consensus of $6.67.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on CDNA:
